Enfusion, Inc. (ENFN)
NYSE: ENFN · Real-Time Price · USD
11.10
-0.04 (-0.36%)
At close: Mar 28, 2025, 4:00 PM
11.14
+0.04 (0.34%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Enfusion Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Enfusion stock have an average target of 12.25, with a low estimate of 11.5 and a high estimate of 13. The average target predicts an increase of 10.36% from the current stock price of 11.10.
Analyst Consensus: Buy
* Price targets were last updated on Dec 23, 2024.
Analyst Ratings
The average analyst rating for Enfusion stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 1 | 2 | 2 | 2 |
| Sell | 2 | 2 | 2 | 2 | 2 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 6 | 6 | 5 | 6 | 6 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 13, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $10 → $12 | Hold | Maintains | $10 → $12 | +3.60% | Dec 23, 2024 |
| Stifel | Stifel | Strong Buy Maintains $11 → $13 | Strong Buy | Maintains | $11 → $13 | +17.12% | Dec 18, 2024 |
| B of A Securities | B of A Securities | Sell Maintains $8 → $9 | Sell | Maintains | $8 → $9 | -18.92% | Mar 13, 2024 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $9 → $8 | Hold → Strong Sell | Downgrades | $9 → $8 | -27.93% | Feb 28, 2024 |
Financial Forecast
Revenue This Year
242.51M
from 201.61M
Increased by 20.29%
Revenue Next Year
284.22M
from 242.51M
Increased by 17.20%
EPS This Year
0.29
from 0.03
Increased by 870.42%
EPS Next Year
0.38
from 0.29
Increased by 31.18%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 255.2M | 305.3M | 319.9M |
| Avg | 242.5M | 284.2M | 310.7M |
| Low | 226.5M | 261.6M | 298.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 26.6% | 25.9% | 12.5% |
| Avg | 20.3% | 17.2% | 9.3% |
| Low | 12.3% | 7.9% | 5.0% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.37 | 0.48 |
| Avg | 0.29 | 0.38 |
| Low | 0.21 | 0.28 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | 1,116.1% | 64.7% |
| Avg | 870.4% | 31.2% |
| Low | 581.0% | -3.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.